Screening of promising chemotherapeutic candidates from plants extracts

Junei Kinjo1, Daisuke Nakano2, Toshihiro Fujioka2

  • 1Faculty of Pharmaceutical Sciences, Fukuoka University, 8-19-1 Nanakuma, Jonan-ku, Fukuoka, 814-0180, Japan. kinjojun@fukuoka-u.ac.jp.

Insights

Researchers screened 582 plant extracts for anti-cancer properties. Withanolide emerged as a promising chemotherapeutic candidate due to its selective cytotoxicity against cancer cell lines.

Area of Science:

  • Natural Product Chemistry
  • Pharmacology
  • Cancer Biology

Background:

  • Investigating plant-derived compounds for anti-proliferative effects against various cancer cell lines.
  • Screening of 582 extracts from 370 plants to identify potential anti-cancer agents.

Purpose of the Study:

  • To identify and characterize plant-derived compounds with selective anti-proliferative activity against human gastric adenocarcinoma (MK-1), human uterine carcinoma (HeLa), and murine melanoma (B16F10) cells.
  • To determine the structure-activity relationships of identified compounds.
  • To evaluate the chemotherapeutic potential of promising candidates.

Main Methods:

  • Activity-guided fractionation and isolation of active compounds from plant extracts.
  • Structure-activity relationship (SAR) studies to identify key structural features responsible for activity and selectivity.
  • Cytotoxicity assays to determine EC50 values and selectivity against cancer cell lines and control cells.

Main Results:

  • Several plant extracts exhibited anti-proliferative activity, though some showed general toxicity.
  • Specific compounds like polyacetylenes, a 3,4-dihydroxyphenethyl derivative, 6-methoxyflavone derivatives, and 8-hydroxy furanocoumarins demonstrated selective activity against MK-1, B16F10, and HeLa cells, respectively.
  • 24, 25-dihydrowithanolide D showed significant selective cytotoxicity, with a 100-fold higher effective concentration against control cells compared to cancer cells.

Conclusions:

  • Withanolide compounds, particularly 24, 25-dihydrowithanolide D, represent promising candidates for further development as selective chemotherapeutic agents.
  • Understanding SAR is crucial for optimizing anti-cancer drug design and minimizing off-target effects.